Retail Clinics

SILVER SPRING, Md. — The Food and Drug Administration on Thursday informed the public that continued use of a Type 2 diabetes treatment made by Takeda Pharmaceuticals for more than one year may be associated with an increased risk of bladder cancer.

ATLANTA — Many adults across the United States opted to visit their local drug store or supermarket to receive their flu shot during the 2010-2011 influenza season, according to the Centers for Disease Control and Prevention's "Morbidity and Mortality Weekly Report."

BEAVERTON, Ore. — Little Busy Bodies has introduced its latest Boogie Wipes product line that caters to adults' dry, chapped noses.

Saline Soothers are designed to provide adults with a more comfortable alternative to dry tissues, the company said. Little Busy Bodies entered the mucus management market in 2007 with Boogie Wipes, designed just for kids.

RICHMOND, Va. — Patients who used a calendar blister packaging system for their medications showed greater medication adherence than those using traditional vials, according to a new study published in the journal Clinical Therapeutics.

DALLAS — The market for electronic medical records in the United States may exceed $6 billion in value in five years, according to a new report by research firm MarketsandMarkets.

In the report, “U.S. Electronic Medical Records (EMR) Market, 2010-2015 (Market Share, Winning Strategies and Adoption Trends),” released this month, the firm said that the market was expected to grow from $2.17 billion in 2009 to $6.05 billion in 2015.

INDIANAPOLIS — A new oral medication for Type 2 diabetes made by Eli Lilly and Boehringer Ingelheim has become available in pharmacies, the companies said Wednesday.

Lilly and BI announced the availability of Tradjenta (linagliptin) in chain and independent pharmacies around the country.

SILVER SPRING, Md. — One month after the observance of Skin Cancer Awareness Month, the Food and Drug Administration announced Tuesday it is taking measures to assure all sunscreen products are safe and effective.

NEW YORK — Sunbow officially unveiled at a press event in New York on Wednesday its new line of sun care products specially designed for children.

The new product line is comprised of seven SKUs formulated with micronized zinc oxide formulas to provide a strong UVA/UVB barrier without the chemical actives, such as oxybenzone or octinoxate.